University Hospital, Geneva

This early-phase trial tests a personalized immunotherapy called MVX-ONCO-2 for people with advanced solid tumors that have not responded to standard treatments. The therapy uses a patient's own tumor cells to create a vaccine that stimulates their immune system to fight the canc…

This study looks back at 376 patients who received LSD or psilocybin therapy for hard-to-treat depression, anxiety, PTSD, or addiction. Researchers want to see if the intensity of the psychedelic experience relates to better outcomes. No new treatments are given—only existing med…